Signaling for the caspases: Their role in prostate cell apoptosis

被引:33
作者
Coffey, RNT [1 ]
Watson, RWG [1 ]
Fitzpatrick, JM [1 ]
机构
[1] Univ Coll Dublin, Mater Misericordiae Hosp, Dept Surg, Dublin, Ireland
关键词
prostate; apoptosis; caspases; prostatic neoplasms; signal transduction;
D O I
10.1097/00005392-200101000-00003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The caspases are an evolutionary conserved family of cell death proteases. Their activation during apoptosis is an important underlying theme in prostate cancer therapy. We summarize the signaling pathways leading to the recruitment of the caspases and address the importance of recent therapeutic strategies aimed at specifically targeting these proteases in relation to prostate cancer. Materials and Methods: We present a background introduction into the role of the caspases in apoptosis and how failure to signal effectively their activation may contribute to prostate cancer progression. Key studies aimed at specifically targeting the caspases as cancer therapy are discussed. Results: Prostate carcinogenesis and apoptosis are related. The deregulation of apoptosis contributes to tumor initiation, metastasis and progression to the androgen insensitive state. Conversely the effectiveness of therapy often depends on its ability to induce apoptosis in prostate cancer cells. Identifying abnormalities in the apoptotic signaling pathway has greatly contributed to understanding the biology of prostate cancer. Elucidating caspase regulation has contributed to the design of novel therapies for prostate cancer. Conclusions: We summarize the physiological and pathological pathways leading to caspase activation in the prostate and describe novel approaches that target these proteases.
引用
收藏
页码:5 / 14
页数:10
相关论文
共 158 条
[21]  
COFFEY RNT, 1999, SURG FORUM, V50, P702
[22]   Apoptosis in prostate cancer - Molecular basis to study hormone refractory mechanisms [J].
Colombel, M ;
Diez, SG ;
Radvanyi, F ;
Buttyan, R ;
Thiery, JP ;
Chopin, D .
BASIS FOR CANCER MANAGEMENT, 1996, 784 :63-69
[23]   CALCIUM-CHANNEL ANTAGONISTS DELAY REGRESSION OF ANDROGEN-DEPENDENT TISSUES AND SUPPRESS GENE ACTIVITY ASSOCIATED WITH CELL-DEATH [J].
CONNOR, J ;
SAWCZUK, IS ;
BENSON, MC ;
TOMASHEFSKY, P ;
OTOOLE, KM ;
OLSSON, CA ;
BUTTYAN, R .
PROSTATE, 1988, 13 (02) :119-130
[24]   Protein kinase c isoenzyme patterns characteristically modulated in early prostate cancer [J].
Cornford, P ;
Evans, J ;
Dodson, A ;
Parsons, K ;
Woolfenden, A ;
Neoptolemos, J ;
Foster, CS .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (01) :137-144
[25]   Camptothecin sensitizes androgen-independent prostate cancer cells to anti Fas-induced apoptosis [J].
Costa-Pereira, AP ;
Cotter, TG .
BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) :371-378
[26]   Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen [J].
Dannull, J ;
Belldegrun, AS .
BRITISH JOURNAL OF UROLOGY, 1997, 79 :97-103
[27]  
de la Taille A, 1999, PROSTATE, V40, P89, DOI 10.1002/(SICI)1097-0045(19990701)40:2<89::AID-PROS4>3.0.CO
[28]  
2-E
[29]  
Denmeade S R, 1996, Adv Pharmacol, V35, P281, DOI 10.1016/S1054-3589(08)60278-1
[30]  
Denmeade SR, 1998, CANCER J SCI AM, V4, pS15